A180 100ML
$120.00
A180 100ML In cattle: Treatment of bovine respiratory illness caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. A180 100ML For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin. In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacinVM 42058/4000 Vet A180 (Canada) Print Share A180 (Canada) This page contains information on A180 for veterinary use. The information provided typically includes the following: A180 Indications Warnings and cautions for A180 Direction and dosage information for A180 This treatment applies to the following species: Beef Cattle danofloxacin mesylate sterile injectable solution Veterinary Use Only
Description
A180 100ML Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin. In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacin
Description A180 100ML In cattle: Treatment of bovine respiratory illness caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. A180 100ML For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin. In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacinVM 42058/4000 Vet A180 (Canada) Print Share A180 (Canada) This page contains information on A180 for veterinary use. The information provided typically includes the following: A180 Indications
Warnings and cautions for A180 Direction and dosage information for A180 A180 This treatment applies to the following species: Beef Cattle danofloxacin mesylate sterile injectable solution Veterinary Use Only
A180 Injectable Solution is a sterile solution containing danofloxacin mesylate, a synthetic fluoroquinolone antimicrobial agent. Danofloxacin mesylate is the non-proprietary designation Figure 1. The chemical structure of danofloxacin mesylate Each mL contains 180 mg of danofloxacin (as danofloxacin mesylate) and 2.5 mg phenol as the preservative. A180 Indications For the treatment of bovine respiratory disease associated with Mannheimia haemolytica and Pasteurella multocida.
Dosage and Administration Care should be taken to dose accurately. Administered dose volume should not exceed 15 mL per injection site. Single-Dose Therapy: Administer subcutaneously at 8 mg/kg of body weightas a one-time injection, Multi-Day Therapy: Administer subcutaneously at 6 mg/kg of body weight with this treatment repeated once approximately 48 hours following the first injection In cattle: Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin._x000D_nIn neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacin In cattle: Treatment of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to danofloxacin. For the treatment of acute bovine mastitis caused by Escherichia coli sensitive to danofloxacin. In neo-natal calves: Treatment of enteric infections caused by Escherichia coli sensitive to danofloxacin
Reviews
There are no reviews yet.